These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18508322)

  • 1. Attenuated doses of rituximab for the treatment of adults with autoimmune cytopenias.
    D'arena G; Scalzulli PR; Nobile M; Dell'olio M; Rossi G; Cascavilla N
    Am J Hematol; 2008 Aug; 83(8):686-7. PubMed ID: 18508322
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab in autoimmune pancytopenia: a case report and review of literature.
    Reale LD; Besa EC
    Ann Hematol; 2007 Dec; 86(12):913-6. PubMed ID: 17541587
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent antibody depletion after rituximab in three children with autoimmune cytopenias.
    Adeli MM; Eichner BH; Thornburg C; Williams L
    Pediatr Hematol Oncol; 2009 Nov; 26(8):566-72. PubMed ID: 19954366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides.
    Coppo P; Clauvel JP; Bengoufa D; Fuentes V; Gouilleux-Gruart V; Courvalin JC; Lassoued K
    Am J Hematol; 2004 Nov; 77(3):241-9. PubMed ID: 15495255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.
    Provan D; Butler T; Evangelista ML; Amadori S; Newland AC; Stasi R
    Haematologica; 2007 Dec; 92(12):1695-8. PubMed ID: 18055995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of treatment-resistant autoimmune blistering skin disorders with rituximab.
    Jensen AØ; Møller BK; Vangkilde A; Mark B; Obitz ER; Kragballe K; Iversen L
    Br J Dermatol; 2009 Jun; 160(6):1359-61. PubMed ID: 19416252
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab for the treatment of autoimmune cytopenias.
    Berentsen S
    Haematologica; 2007 Dec; 92(12):1589-96. PubMed ID: 18055980
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases.
    Frikha F; Rigolet A; Behin A; Fautrel B; Herson S; Benveniste O
    Rheumatology (Oxford); 2009 Sep; 48(9):1166-8. PubMed ID: 19549788
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired immune cytopenias post-cardiac transplantation respond to rituximab.
    Tubman VN; Smoot L; Heeney MM
    Pediatr Blood Cancer; 2007 Mar; 48(3):339-44. PubMed ID: 16435382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.
    Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M
    Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab use in pediatric autoimmune diseases: four case reports.
    Polido-Pereira J; Ferreira D; Rodrigues AM; Nascimento C; Costa P; Almeida M; da Silva JE; Simão C; Stone R; Ramos F; Neto A; da Costa JC; Melo-Gomes J; Gomes-Pedro J; Viana-Queiroz M; Canhão H; Fonseca JE
    Ann N Y Acad Sci; 2009 Sep; 1173():712-20. PubMed ID: 19758220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in the treatment of autoimmune haematological disorders.
    Provan D; Newland AC; Amadori S; Stasi R
    Br J Haematol; 2008 Oct; 143(2):294; author reply 295. PubMed ID: 18752592
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the current use of rituximab in autoimmune diseases.
    Gürcan HM; Keskin DB; Stern JN; Nitzberg MA; Shekhani H; Ahmed AR
    Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rituximab on immunocompetency in patients with autoimmune disease.
    Looney RJ; Srinivasan R; Calabrese LH
    Arthritis Rheum; 2008 Jan; 58(1):5-14. PubMed ID: 18163518
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 17. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
    Kittaka K; Dobashi H; Baba N; Iseki K; Kameda T; Susaki K; Kitanaka A; Kubota Y; Ishida T
    Scand J Rheumatol; 2008; 37(5):390-3. PubMed ID: 18609263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases.
    Bussone G; Ribeiro E; Dechartres A; Viallard JF; Bonnotte B; Fain O; Godeau B; Michel M
    Am J Hematol; 2009 Mar; 84(3):153-7. PubMed ID: 19123460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab treatment in children: comment on the review by Looney et al.
    Bader-Meunier B
    Arthritis Rheum; 2008 Aug; 58(8):2583; author reply 2583-4. PubMed ID: 18668567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.